1. Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Concise Review with a Comprehensive Summary of Therapeutic Interventions Emphasizing Supportive Measures

   • Jeremy A. Schneider
   • Philip R. Cohen

   Review Open access 24 April 2017 Pages: 1235 - 1244

2. Repurposing Pentoxifylline for the Treatment of Fibrosis: An Overview

   • Wei Xiong Wen
   • Siang Yin Lee
   • Rhun Yian Koh

   Review 08 May 2017 Pages: 1245 - 1269

   

3. Ranibizumab in the Treatment of Diabetic Macular Edema: A Review of the Current Status, Unmet Needs, and Emerging Challenges

   • Nikolaos Dervenis
   • Athanasia Maria Mikropoulou
   • Panagiotis Dervenis

   Review Open access 08 May 2017 Pages: 1270 - 1282

   

4. Non-Vitamin K Oral Anticoagulants for Stroke Prevention in Special Populations with Atrial Fibrillation

   • Arnaud Bisson
   • Denis Angoulvant
   • Laurent Fauchier

   Review Open access 10 May 2017 Pages: 1283 - 1290

5. NAFLD as a Sexual Dimorphic Disease: Role of Gender and Reproductive Status in the Development and Progression of Nonalcoholic Fatty Liver Disease and Inherent Cardiovascular Risk

   • Stefano Ballestri
   • Fabio Nascimbeni
   • Amedeo Lonardo

   Review Open access 19 May 2017 Pages: 1291 - 1326

   

6. Secukinumab is Efficacious and Safe in Hispanic Patients with Moderate-to-Severe Plaque Psoriasis: Pooled Analysis of Four Phase 3 Trials

   • Sandra Adsit
   • Enrique Rivas Zaldivar
   • Adriana Guana

   Original Research Open access 10 April 2017 Pages: 1327 - 1339

   

7. Is There a Role for Ivabradine in the Contemporary Management of Patients with Chronic Heart Failure in Academic and Community Heart Failure Clinics in Canada?

   • Sherryn Roth
   • Carlos Fernando
   • Gordon W. Moe

   Original Research 21 April 2017 Pages: 1340 - 1348

8. The GENDER ATTENTION Observational Study: Gender and Hormonal Status Differences in the Incidence of Adverse Events During Cyclosporine Treatment in Psoriatic Patients

   • Delia Colombo
   • Giuseppe Banfi
   • On behalf of the GENDER ATTENTION study group

   Original Research Open access 21 April 2017 Pages: 1349 - 1363

   

9. RPC4046, A Novel Anti-interleukin-13 Antibody, Blocks IL-13 Binding to IL-13 α1 and α2 Receptors: A Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation First-in-Human Study

   • Catherine S. Tripp
   • Carolyn Cuff
   • Kenneth Kim

   Original Research Open access 28 April 2017 Pages: 1364 - 1381

   

10. Management of Grass Pollen Allergy with 5-Grass Pollen Tablet: Results of a 2-Year Real-Life Study

    • Kija Shah-Hosseini
    • Eva-Maria Krudewig
    • Ralph Mösges

    Original Research Open access 28 April 2017 Pages: 1382 - 1397

    

11. Predicting Pre-emptive Discussions of Biologic Treatment: Results from an Openness and Preference Survey of Inflammatory Bowel Disease Patients and Their Prescribers

    • M. Furaha Kariburyo
    • Lin Xie
    • Michael Ingham

    Original Research Open access 08 May 2017 Pages: 1398 - 1410

    

12. Prospective Observational Post-Marketing Study of Tafluprost for Glaucoma and Ocular Hypertension: Effectiveness and Treatment Persistence

    • Yasuaki Kuwayama
    • Masako Hashimoto
    • Fumiki Shimada

    Original Research 13 May 2017 Pages: 1411 - 1425

    

13. Perceptions of Painful Diabetic Peripheral Neuropathy in South-East Asia: Results from Patient and Physician Surveys

    • Rayaz A. Malik
    • Emre Aldinc
    • Bruce Parsons

    Original Research Open access 13 May 2017 Pages: 1426 - 1437

    

14. Multicenter, Randomized, Investigator-Masked Study Comparing Brimonidine Tartrate 0.1% and Timolol Maleate 0.5% as Adjunctive Therapies to Prostaglandin Analogues in Normal-Tension Glaucoma

    • Shiro Mizoue
    • Koji Nitta
    • Keiji Yoshikawa

    Original Research 15 May 2017 Pages: 1438 - 1448

    

15. Randomized Phase 3 Trial of Ombitasvir/Paritaprevir/Ritonavir and Ribavirin for Hepatitis C Virus Genotype 2-Infected Japanese Patients

    • Ken Sato
    • Kazuaki Chayama
    • Hiromitsu Kumada

    Original Research 23 May 2017 Pages: 1449 - 1465

    

16. Life Impact and Treatment Preferences of Individuals with Asthma and Chronic Obstructive Pulmonary Disease: Results from Qualitative Interviews and Focus Groups

    • Henrik Svedsater
    • June Roberts
    • Lisa Bradshaw

    Original Research Open access 23 May 2017 Pages: 1466 - 1481

    

17. Genetic Variants Within Key Nodes of the Cascade of Antipsychotic Mechanisms: Effects on Antipsychotic Response and Schizophrenia Psychopathology in a Naturalistic Treatment Setting in Two Independent Korean and Italian Samples

    • Marco Calabrò
    • Stefano Porcelli
    • Alessandro Serretti

    Original Research 16 May 2017 Pages: 1482 - 1497

18. Erratum to: Efficacy of Zofenopril vs. Irbesartan in Combination with a Thiazide Diuretic in Hypertensive Patients with Multiple Risk Factors not Controlled by a Previous Monotherapy: A Review of the Double-Blind, Randomized “Z” Studies

    • Stefano Omboni
    • Ettore Malacco
    • Claudio Borghi

    Erratum Open access 27 April 2017 Pages: 1498 - 1499

19. Erratum to: Evaluation of the Short-Term Cost-Effectiveness of IDegLira Versus Continued Up-Titration of Insulin Glargine U100 in Patients with Type 2 Diabetes in the USA

    • Barnaby Hunt
    • Michelle Mocarski
    • Jakob Langer

    Erratum Open access 18 May 2017 Pages: 1500 - 1501